EP3471562A4 - Synthetic compositions comprising human milk oligosaccharides for use the prevention and treatment of disorders - Google Patents
Synthetic compositions comprising human milk oligosaccharides for use the prevention and treatment of disorders Download PDFInfo
- Publication number
- EP3471562A4 EP3471562A4 EP17812794.0A EP17812794A EP3471562A4 EP 3471562 A4 EP3471562 A4 EP 3471562A4 EP 17812794 A EP17812794 A EP 17812794A EP 3471562 A4 EP3471562 A4 EP 3471562A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- disorders
- prevention
- treatment
- human milk
- milk oligosaccharides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 208000035475 disorder Diseases 0.000 title 1
- 210000004251 human milk Anatomy 0.000 title 1
- 235000020256 human milk Nutrition 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 229920001542 oligosaccharide Polymers 0.000 title 1
- 150000002482 oligosaccharides Chemical class 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15/183,391 US10835544B2 (en) | 2014-12-08 | 2016-06-15 | Synthetic composition for regulating satiety |
US15/183,431 US10987368B2 (en) | 2014-12-08 | 2016-06-15 | Synthetic composition for preventing or treating CVD |
US15/183,404 US10881674B2 (en) | 2014-12-08 | 2016-06-15 | Synthetic composition for treating metabolic disorders |
PCT/DK2017/050198 WO2017215721A1 (en) | 2016-06-15 | 2017-06-15 | Synthetic compositions comprising human milk oligosaccharides for use γν the prevention and treatment of disorders |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3471562A1 EP3471562A1 (en) | 2019-04-24 |
EP3471562A4 true EP3471562A4 (en) | 2020-07-29 |
Family
ID=60663363
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP17812794.0A Pending EP3471562A4 (en) | 2016-06-15 | 2017-06-15 | Synthetic compositions comprising human milk oligosaccharides for use the prevention and treatment of disorders |
Country Status (2)
Country | Link |
---|---|
EP (1) | EP3471562A4 (en) |
WO (1) | WO2017215721A1 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2021094993A1 (en) * | 2019-11-14 | 2021-05-20 | Glycom A/S | Synthetic composition for balancing the bile acid profile in the intestine |
WO2021123253A1 (en) * | 2019-12-19 | 2021-06-24 | Basf Se | Composition for the treatment of (pre)hyperglycemia and/or associated morbidities thereto |
EP4096440B1 (en) * | 2020-01-31 | 2024-04-03 | N.V. Nutricia | Nutritional composition for use in gut maturation |
WO2021191251A1 (en) * | 2020-03-25 | 2021-09-30 | Frieslandcampina Nederland B.V. | COMPOSITIONS COMPRISING ONE OR MORE HMO'S WITH A CORE OF LacNAc-Lac |
TW202233201A (en) * | 2020-12-16 | 2022-09-01 | 荷蘭商弗里斯蘭康必奶荷蘭有限公司 | Synthetic compositions comprising lnfp iii and lsta |
CN114145353A (en) * | 2021-11-30 | 2022-03-08 | 内蒙古伊利实业集团股份有限公司 | Formula milk powder capable of improving intestinal microenvironment health and preparation method and application thereof |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5906982A (en) * | 1997-03-31 | 1999-05-25 | Abbott Laboratories | Nutritional formulations containing Lacto-N-neoTetraose |
EP1962617A2 (en) * | 2005-12-23 | 2008-09-03 | N.V. Nutricia | Infant nutritional compositions for preventing obesity |
EP2072052A1 (en) * | 2007-12-17 | 2009-06-24 | Nestec S.A. | Prevention of opportunistic infections in immune-compromised subjects |
RU2478309C2 (en) * | 2007-12-21 | 2013-04-10 | Н.В. Нютрисиа | Sphingomyelin and indigestible carbohydrates usage for gut microbiota normalisation |
WO2011119023A1 (en) * | 2010-03-26 | 2011-09-29 | N.V. Nutricia | Low protein infant formula with increased essential amino acids |
RU2604503C2 (en) * | 2011-10-18 | 2016-12-10 | Нестек С.А. | Composition for use in increasing insulin sensitivity and/or reducing insulin resistance |
US20160113952A1 (en) * | 2013-05-22 | 2016-04-28 | Glycom As | Synthetic Mixture of Oligosaccharides for Treating a Microbiota of a Mammal |
US20150305385A1 (en) * | 2014-04-25 | 2015-10-29 | Mead Johnson Nutrition Company | Pediatric nutritional composition with human milk oligosaccahrides, prebiotics and probiotics |
WO2016091265A1 (en) * | 2014-12-08 | 2016-06-16 | Glycom A/S | Synthetic composition for treating metabolic disorders |
EP3407892A1 (en) * | 2016-01-26 | 2018-12-05 | Nestec S.A. | Compositions comprising sialylated oligosaccharides for use in infants or young children to prevent later in life obesity or related comorbidities and promote a healthy growth |
BR112018013538A2 (en) * | 2016-01-26 | 2018-12-04 | Nestec S.A. | compositions comprising 2fl and lnnt for use in infants or young children to prevent obesity, or related comorbidities, in later stages of life. |
WO2017129648A1 (en) * | 2016-01-26 | 2017-08-03 | Nestec S.A. | Human milk oligosaccharides for health benefits by prevention of premature adiposity rebound |
EP3407897A1 (en) * | 2016-01-26 | 2018-12-05 | Nestec S.A. | Compositions comprising human milk oligosaccharides for use in infants or young children to prevent or treat a health disorder by increasing glp-1 secretion |
-
2017
- 2017-06-15 WO PCT/DK2017/050198 patent/WO2017215721A1/en unknown
- 2017-06-15 EP EP17812794.0A patent/EP3471562A4/en active Pending
Non-Patent Citations (1)
Title |
---|
No further relevant documents disclosed * |
Also Published As
Publication number | Publication date |
---|---|
EP3471562A1 (en) | 2019-04-24 |
WO2017215721A1 (en) | 2017-12-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3675882A4 (en) | Methods and compositions for treatment of microbiome-associated disorders | |
IL298689B1 (en) | Compositions and methods of inhibiting masp-3 for the treatment of various diseases and disorders | |
EP3448398A4 (en) | Compositions and methods for treatment of skin disorders | |
EP3370748A4 (en) | Therapeutic microbiota for the treatment and/or prevention of food allergy | |
PT3377637T (en) | Compositions and methods for the treatment of wounds, disorders, and diseases of the skin | |
EP3471562A4 (en) | Synthetic compositions comprising human milk oligosaccharides for use the prevention and treatment of disorders | |
EP3621973A4 (en) | Compounds for the prevention and treatment of diseases and the use thereof | |
EP3405215A4 (en) | Methods for the treatment of danon disease and other disorders of autophagy | |
ZA202002066B (en) | Compositions and methods for the treatment of eye disorders | |
EP3558279A4 (en) | Compositions and methods for the treatment of chronic pain | |
EP3277287B8 (en) | Mixtures of human milk oligosaccharides comprising 3 '-o-sialyllactose | |
EP3352749A4 (en) | Compounds and compositions for the treatment of ocular disorders | |
IL263477A (en) | Compositions and methods for the treatment or prevention of oxalate-related disorders | |
EP3639833A4 (en) | Agent for the prevention or treatment of fat-related diseases and/or inflammation | |
IL272097A (en) | Compounds for the prevention and treatment of medical disorders and uses thereof | |
IL269400A (en) | Drugs and compositions for the treatment of ocular disorders | |
EP3518951A4 (en) | Compositions and methods for the treatment of orthopedic ailments | |
EP3506899A4 (en) | Compositions and methods for the diagnosis and treatment of lymphatic system disorders | |
EP3452169A4 (en) | Methods and formulations for treatment and/or prevention of blood-associated disorders | |
EP3856147A4 (en) | Methods and probiotic compositions for the treatment of bone disorders | |
EP3261446A4 (en) | Methods and compositions for the treatment or prevention of parkinson's disease | |
EP3846851A4 (en) | Compositions and methods for the diagnosis and treatment of lymphatic system disorders | |
EP3119387A4 (en) | Compositions for the treatment of dermatological diseases and disorders | |
EP3568138A4 (en) | Compositions and methods for the treatment of myelin related and inflammation related diseases or disorders | |
EP3668836A4 (en) | Compositions for the treatment of dry eye and methods of use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20190115 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 31/702 20060101ALI20200123BHEP Ipc: A61P 3/04 20060101ALN20200123BHEP Ipc: A23L 33/125 20160101AFI20200123BHEP Ipc: A61P 3/10 20060101ALN20200123BHEP Ipc: A61P 9/10 20060101ALN20200123BHEP |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20200626 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61P 9/10 20060101ALN20200622BHEP Ipc: A61P 3/04 20060101ALN20200622BHEP Ipc: A61P 3/10 20060101ALN20200622BHEP Ipc: A23L 33/125 20160101AFI20200622BHEP Ipc: A61K 31/702 20060101ALI20200622BHEP |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
17Q | First examination report despatched |
Effective date: 20230922 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |